1 - 10 out of 22Page size: 10
  1. 2023

  2. Bispecific antibodies combine breadth, potency, and avidity of parental antibodies to neutralize sarbecoviruses

    Radić, L., Sliepen, K., Yin, V., Brinkkemper, M., Capella-Pujol, J., Schriek, A. I., Torres, J. L., Bangaru, S., Burger, J. A., Poniman, M., Bontjer, I., Bouhuijs, J. H., Gideonse, D., Eggink, D., Ward, A. B., Heck, A. J. R., van Gils, M. J., Sanders, R. W. & Schinkel, J., 21 Apr 2023, In: iScience. 26, 4, 106540.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2022

  4. Co-display of diverse spike proteins on nanoparticles broadens sarbecovirus neutralizing antibody responses

    Brinkkemper, M., Veth, T. S., Brouwer, P. J. M., Turner, H., Poniman, M., Burger, J. A., Bouhuijs, J. H., Olijhoek, W., Bontjer, I., Snitselaar, J. L., Caniels, T. G., van der Linden, C. A., Ravichandran, R., Villaudy, J., van der Velden, Y. U., Sliepen, K., van Gils, M. J., Ward, A. B., King, N. P., Heck, A. J. R., & 1 othersSanders, R. W., 22 Dec 2022, In: iScience. 25, 12, 105649.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike

    Claireaux, M., Caniels, T. G., de Gast, M., Han, J., Guerra, D., Kerster, G., van Schaik, B. D. C., Jongejan, A., Schriek, A. I., Grobben, M., Brouwer, P. J. M., van der Straten, K., Aldon, Y., Capella-Pujol, J., Snitselaar, J. L., Olijhoek, W., Aartse, A., Brinkkemper, M., Bontjer, I., Burger, J. A., & 13 othersPoniman, M., Bijl, T. P. L., Torres, J. L., Copps, J., Martin, I. C., de Taeye, S. W., de Bree, G. J., Ward, A. B., Sliepen, K., van Kampen, A. H. C., Moerland, P. D., Sanders, R. W. & van Gils, M. J., 1 Dec 2022, In: Nature communications. 13, 1, 4539.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike

    van der Velden, Y. U., Grobben, M., Caniels, T. G., Burger, J. A., Poniman, M., Oomen, M., Rijnstra, E. S., Tejjani, K., Guerra, D., Kempers, R., Stegmann, T., van Gils, M. J. & Sanders, R. W., 1 Dec 2022, In: Scientific reports. 12, 1, 3884.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern

    van Rijswijck, D. M. H., Bondt, A., Hoek, M., van der Straten, K., Caniels, T. G., Poniman, M., Eggink, D., Reusken, C., de Bree, G. J., Sanders, R. W., van Gils, M. J. & Heck, A. J. R., 1 Dec 2022, In: Nature communications. 13, 1, 6103.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions (Front. Immunol., (2022), 13, 893648, 10.3389/fimmu.2022.893648)

    Schriek, A. I., van Haaren, M. M., Poniman, M., Dekkers, G., Bentlage, A. E. H., Grobben, M., Vidarsson, G., Sanders, R. W., Verrips, T., Geijtenbeek, T. B. H., Heukers, R., Kootstra, N. A., de Taeye, S. W. & van Gils, M. J., 22 Nov 2022, In: Frontiers in immunology. 13, 1091668.

    Research output: Contribution to journal › Comment/Letter to the editor › Academic

  9. Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection

    Lavell, A. H. A., Sikkens, J. J., Edridge, A. W. D., van der Straten, K., Sechan, F., Oomen, M., Buis, D. T. P., Schinkel, M., Burger, J. A., Poniman, M., van Rijswijk, J., de Jong, M. D., de Bree, G. J., Peters, E. J. G., Smulders, Y. M., Sanders, R. W., van Gils, M. J., van der Hoek, L. & Bomers, M. K., 21 Oct 2022, In: iScience. 25, 10, 105105.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron

    van der Straten, K., Guerra, D., van Gils, M. J., Bontjer, I., Caniels, T. G., van Willigen, H. D. G., Wynberg, E., Poniman, M., Burger, J. A., Bouhuijs, J. H., van Rijswijk, J., Olijhoek, W., Liesdek, M. H., Lavell, A. H. A., Appelman, B., Sikkens, J. J., Bomers, M. K., Han, A. X., Nichols, B. E., Prins, M., & 7 othersVennema, H., Reusken, C., de Jong, M. D., de Bree, G. J., Russell, C. A., Eggink, D. & Sanders, R. W., 13 Sept 2022, In: Immunity. 55, 9, p. 1725-1731.e4

    Research output: Contribution to journal › Article › Academic › peer-review

  11. Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity

    van Leeuwen, L. P. M., GeurtsvanKessel, C. H., Ellerbroek, P. M., de Bree, G. J., Potjewijd, J., Rutgers, A., Jolink, H., van de Veerdonk, F., van Gorp, E. C. M., de Wilt, F., Bogers, S., Gommers, L., Geers, D., Bruns, A. H. W., Leavis, H. L., van Haga, J. W., Lemkes, B. A., van der Veen, A., de Kruijf-Bazen, S. F. J., van Paassen, P., & 17 othersde Leeuw, K., van de Ven, A. A. J. M., Verbeek-Menken, P. H., van Wengen, A., Arend, S. M., Ruten-Budde, A. J., van der Ent, M. W., van Hagen, P. M., Sanders, R. W., Grobben, M., van der Straten, K., Burger, J. A., Poniman, M., Nierkens, S., van Gils, M. J., de Vries, R. D. & Dalm, V. A. S. H., Jun 2022, In: Journal of allergy and clinical immunology. 149, 6, p. 1949-1957 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  12. Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions

    Schriek, A. I., van Haaren, M. M., Poniman, M., Dekkers, G., Bentlage, A. E. H., Grobben, M., Vidarsson, G., Sanders, R. W., Verrips, T., Geijtenbeek, T. B. H., Heukers, R., Kootstra, N. A., de Taeye, S. W. & van Gils, M. J., 16 May 2022, In: Frontiers in immunology. 13, 893648.

    Research output: Contribution to journal › Article › Academic › peer-review

Previous 1 2 3 Next

ID: 11061160